In vitro activities of clinafloxacin against contemporary clinical bacterial isolates from 10 North American centers

被引：16

作者：

Fuchs, PC ^{[1
]}

Barry, AL ^{[1
]}

Brown, SD ^{[1
]}

机构：

[1] Inst Clin Microbiol, Wilsonville, OR 97070 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1998年 / 42卷 / 05期

关键词：

D O I：

10.1128/AAC.42.5.1274

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Clinafloxacin was more active than ciprofloxacin against 4,213 aerobic and facultative anaerobic bacterial isolates from 10 medical centers, as tested by broth microdilution and disk diffusion methods. The percentage of 201 anaerobes susceptible to clinafloxacin by broth microdilution was comparable to cefoxitin. Our data support the proposed disk diffusion interpretive criteria for aerobic bacteria with 5-mu g clinafloxacin disks.

引用

收藏

页码：1274 / 1277

页数：4

相关论文

共 14 条

[1] The tolerance and pharmacokinetics of clinafloxacin (CI-960) in healthy subjects [J].

Bron, NJ ;

Dorr, MB ;

Mant, TG ;

Webb, CL ;

Vassos, AB .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (06) :1023-1029

[2] ACTIVITIES OF 3 INVESTIGATIONAL FLUOROQUINOLONES (BAY-Y-3118, DU-6859A, AND CLINAFLOXACIN) AGAINST NEISSERIA-GONORRHOEAE ISOLATES WITH DIMINISHED SUSCEPTIBILITIES TO CIPROFLOXACIN AND OFLOXACIN [J].

CARLYN, CJ ;

DOYLE, LJ ;

KNAPP, CC ;

LUDWIG, MD ;

WASHINGTON, JA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) :1606-1608

[3] IN-VITRO AND IN-VIVO ACTIVITIES OF CLINAFLOXACIN, CI-990 (PD-131112), AND PD-138312 VERSUS ENTEROCOCCI [J].

COHEN, MA ;

YODER, SL ;

HUBAND, MD ;

ROLAND, GE ;

COURTNEY, CL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (09) :2123-2127

[4] MULTICENTER EVALUATION OF THE INVITRO ACTIVITIES OF 3 NEW QUINOLONES, SPARFLOXACIN, CI-960, AND PD-131,628, COMPARED WITH THE ACTIVITY OF CIPROFLOXACIN AGAINST 5,252 CLINICAL BACTERIAL ISOLATES [J].

FUCHS, PC ;

BARRY, AL ;

PFALLER, MA ;

ALLEN, SD ;

GERLACH, EH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (04) :764-766

[5] SUSCEPTIBILITY OF CIPROFLOXACIN-RESISTANT STAPHYLOCOCCI AND ENTEROCOCCI TO CLINAFLOXACIN [J].

HARRINGTON, GD ;

ZARINS, LT ;

RAMSEY, MA ;

BRADLEY, SF ;

KAUFFMAN, C .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1995, 21 (01) :27-31

[6] In vitro susceptibility of anaerobes to quinolones in the United States [J].

Hecht, DW ;

Wexler, HM .

CLINICAL INFECTIOUS DISEASES, 1996, 23 :S2-S8

[7] The comparative in vitro activity of clinafloxacin and other antimicrobials against vancomycin-susceptible and vancomycin-resistant enterococci [J].

Itokazu, GS ;

Nathan, C ;

Hariharan, R ;

Kostman, JR ;

Kabins, SA ;

Weinstein, RA .

CHEMOTHERAPY, 1996, 42 (04) :235-239

[8] MODIFICATIONS FOR DISK DIFFUSION SUSCEPTIBILITY TESTING CRITERIA OF CLINAFLOXACIN (CI-960, AM-1091, PD127371) AND FLEROXACIN (RO-23-6240, AM-833) FOLLOWING STUDIES WITH A CHALLENGE PANEL OF CIPROFLOXACIN-RESISTANT CLINICAL ISOLATES [J].

JONES, RN ;

JOHNSON, DM .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1995, 21 (04) :209-213

[9]

*NAT COMM CLIN LAB, 1993, METH ANT SUSC TEST A

[10]

*NAT COMM CLIN LAB, 1997, M2A5 NAT COMM CLIN L